Table I.
Variable | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Age | – | −.06 | −.05 | .26* | .04 | −.13 | −.02 | −.12 | .04 | .08 | .09 | −.03 | .00 | .23* | .09 | −.15 | −.15 |
2. Gender | – | −.01 | −.06 | .11 | .02 | −.11 | .13 | −.01 | −.04 | −.03 | −.06 | −.02 | −.16 | −.06 | .19† | .04 | |
3. Race | – | −.24* | .07 | .08 | .06 | .15 | .01 | .16 | .11 | .14 | .15 | −.05 | −.06 | −.13 | −.04 | ||
4. SES | – | .00 | −.22* | −.16 | −.35** | −.18 | −.04 | −.03 | −.12 | −.19† | −.13 | .16 | −.04 | −.07 | |||
5. T1 Asthma Severity | – | .03 | −.07 | .23* | −.16 | .30** | .12 | −.01 | .08 | −.12 | .10 | .07 | .07 | ||||
6. T1 Parental Depression | – | .39*** | −.08 | .07 | .11 | .49*** | .40*** | −.13 | .01 | .08 | .20† | .23* | |||||
7. T1 Family Functioning | – | −.05 | .12 | .09 | .19† | .66*** | −.17 | .19† | −.04 | −.21† | −.06 | ||||||
8. T1 Eosinophils | – | .34** | .02 | .05 | −.11 | .58*** | .32** | −.16 | .13 | .10 | |||||||
9. T1 ECP | – | −.10 | .04 | .03 | .43*** | .42*** | −.11 | −.10 | .04 | ||||||||
10. T1 Symptoms | – | .11 | .08 | −.05 | −.01 | .48*** | −.12 | −.03 | |||||||||
11. T2 Parental Depression | – | .30** | −.05 | .05 | .04 | .20† | .24* | ||||||||||
12. T2 Family Functioning | – | .18 | .18 | −.05 | −.19† | −.02 | |||||||||||
13. T2 Eosinophils | – | .59*** | −.09 | .05 | .08 | ||||||||||||
14. T2 ECP | – | −.12 | −.05 | .08 | |||||||||||||
15. T2 Symptoms | – | −.04 | .02 | ||||||||||||||
16. T2 Corticosteroid Use | – | .84*** | |||||||||||||||
17. T2 Beta Agonist Use | − | ||||||||||||||||
Mean | 12.6 | .67 | .37 | 2.54 | 2.48 | 9.19 | 1.75 | .37 | 17.8 | .34 | 9.32 | 1.78 | .35 | 24.6 | .26 | 4.12 | 4.36 |
SD | 2.6 | .47 | .49 | 1.01 | .98 | 7.74 | .36 | .28 | 18.2 | .46 | 8.24 | .41 | .28 | 21.0 | .37 | 5.90 | 5.74 |
Note. Gender coded as 0 = female, 1 = male. Race coded as 0 = White, 1 = minority.
†p < .10. *p < .05. **p < .01. ***p < .001.